Creo Medical Group PLC - Asset Resilience Ratio

Latest as of June 2024: -0.29%

Creo Medical Group PLC (CREO) has an Asset Resilience Ratio of -0.29% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

GBX-200.00K

≈ $-24.33 USD Cash + Short-term Investments

Total Assets

GBX69.30 Million

≈ $8.43K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2023)

This chart shows how Creo Medical Group PLC's Asset Resilience Ratio has changed over time. Check Creo Medical Group PLC (CREO) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Creo Medical Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CREO market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX-200.00K	-0.29%
Total Liquid Assets	GBX-200.00K	-0.29%

Asset Resilience Insights

Limited Liquidity: Creo Medical Group PLC maintains only -0.29% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Creo Medical Group PLC Industry Peers by Asset Resilience Ratio

Compare Creo Medical Group PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sinocare Inc SHE:300298	Medical Devices	3.53%
T&R Biofab Co. Ltd KQ:246710	Medical Devices	0.12%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.48%
Pulsenmore Ltd. Ordinary Shares NASDAQ:PLSM	Medical Devices	46.67%
Allmed Solutions Ltd TA:ALMD	Medical Devices	80.03%
Universal Biosensors Inc AU:UBI	Medical Devices	14.72%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Cochlear Ltd AU:COH	Medical Devices	9.76%

Annual Asset Resilience Ratio for Creo Medical Group PLC (2020–2023)

The table below shows the annual Asset Resilience Ratio data for Creo Medical Group PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	20.23%	GBX15.50 Million ≈ $1.89K	GBX76.60 Million ≈ $9.32K	+20.44pp
2022-12-31	-0.20%	GBX-153.00K ≈ $-18.62	GBX75.34 Million ≈ $9.17K	-0.08pp
2020-12-31	-0.12%	GBX-112.00K ≈ $-13.63	GBX92.46 Million ≈ $11.25K	--

pp = percentage points

About Creo Medical Group PLC

LSE:CREO UK Medical Devices

Market Cap

$753.63K

GBX6.19 Billion GBX

Market Cap Rank

#30711 Global

#846 in UK

Share Price

GBX12.75

Change (1 day)

-0.97%

52-Week Range

GBX9.90 - GBX17.75

All Time High

GBX243.00